Works matching IS 00126667 AND DT 2020 AND VI 80 AND IP 2

Results: 9
    1

    24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients.

    Published in:
    Drugs, 2020, v. 80, n. 2, p. 167, doi. 10.1007/s40265-019-01248-0
    By:
    • Craven, E. Randy;
    • Walters, Thomas;
    • Christie, William C.;
    • Day, Douglas G.;
    • Lewis, Richard A.;
    • Goodkin, Margot L.;
    • Chen, Michelle;
    • Wangsadipura, Veronica;
    • Robinson, Michael R.;
    • Bejanian, Marina;
    • for the Bimatoprost SR Study Group;
    • Aung, Tin;
    • Beck, Allen D.;
    • Branch, James D.;
    • Coote, Michael;
    • Crane, Charles J.;
    • Crichton, Andrew;
    • Day, Steven;
    • Durcan, F. Jane;
    • Evans, Richard M.
    Publication type:
    Article
    2
    3
    4
    5

    Voxelotor: First Approval.

    Published in:
    Drugs, 2020, v. 80, n. 2, p. 209, doi. 10.1007/s40265-020-01262-7
    By:
    • Blair, Hannah A.
    Publication type:
    Article
    6
    7
    8

    The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.

    Published in:
    Drugs, 2020, v. 80, n. 2, p. 99, doi. 10.1007/s40265-020-01256-5
    By:
    • Kim, HoUng;
    • Alten, Rieke;
    • Avedano, Luisa;
    • Dignass, Axel;
    • Gomollón, Fernando;
    • Greveson, Kay;
    • Halfvarson, Jonas;
    • Irving, Peter M.;
    • Jahnsen, Jørgen;
    • Lakatos, Péter L.;
    • Lee, JongHyuk;
    • Makri, Souzi;
    • Parker, Ben;
    • Peyrin-Biroulet, Laurent;
    • Schreiber, Stefan;
    • Simoens, Steven;
    • Westhovens, Rene;
    • Danese, Silvio;
    • Jeong, Ji Hoon
    Publication type:
    Article
    9